ArticleThe Journal of clinical investigation2006

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.

Johannes-Peter Stasch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.